U.S., Sept. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07816718) titled 'Sustained Asthma Remission and Reduced RElapse Using a COmprehensive Management Strategy Randomized Control Trial' on Sept. 08.

Brief Summary: This study will evaluate whether specialized tests of airway inflammation and lung abnormalities can better predict asthma remission and relapse than standard clinical assessments in adults with severe asthma who are starting biologic therapy. Participants will be randomly assigned to receive either standard asthma care or a comprehensive management approach guided by specialized biomarker results. Participants will be followed for 12 months and will undergo assessments including questionnai...